Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 62.00 | 117.00 | 0.5299 | 0.4656 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 107.00 | 117.00 | 0.9145 | 0.9144 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 80.00 | 117.00 | 0.6838 | 0.6604 |
| BT-20 | Lapatinib | 1 | uM | 7 | 156.25 | 28.40 | 105.00 | 117.00 | 0.8974 | 0.8968 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 156.25 | 28.40 | 74.00 | 117.00 | 0.6325 | 0.5982 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 156.25 | 28.40 | 123.00 | 117.00 | 1.0513 | 1.0496 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 122.00 | 117.00 | 1.0427 | 1.0414 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.00 | 0.0171 | -0.7271 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 2.00 | 281.00 | 0.0071 | -0.9802 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 299.00 | 281.00 | 1.0641 | 1.1193 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 259.00 | 281.00 | 0.9217 | 0.8535 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 312.50 | 133.67 | 135.00 | 281.00 | 0.4804 | 0.0093 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 250.00 | 281.00 | 0.8897 | 0.7934 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 297.00 | 281.00 | 1.0569 | 1.1060 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 133.67 | 274.00 | 281.00 | 0.9751 | 0.9535 |
| BT-20 | Linsitinib | 1 | uM | 7 | 312.50 | 133.67 | 303.00 | 281.00 | 1.0783 | 1.1457 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 133.67 | 321.00 | 281.00 | 1.1423 | 1.2644 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 279.00 | 281.00 | 0.9929 | 0.9867 | |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 306.00 | 281.00 | 1.0890 | 1.1655 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 312.50 | 133.67 | 346.00 | 281.00 | 1.2313 | 1.4285 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 357.00 | 281.00 | 1.2705 | 1.5004 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 212.00 | 281.00 | 0.7545 | 0.5377 |
| BT-20 | 17-AAG | 10 | uM | 7 | 312.50 | 133.67 | 103.00 | 281.00 | 0.3666 | -0.2158 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 312.50 | 133.67 | 272.00 | 281.00 | 0.9680 | 0.9402 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 312.50 | 133.67 | 129.00 | 281.00 | 0.4591 | -0.0326 |